-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Analyzing Summit Healthcare Acquisition (SMIH) & Its Competitors
Analyzing Summit Healthcare Acquisition (SMIH) & Its Competitors
Summit Healthcare Acquisition (NASDAQ:SMIH – Get Rating) is one of 710 public companies in the "Holding & other investment offices" industry, but how does it contrast to its rivals? We will compare Summit Healthcare Acquisition to similar companies based on the strength of its institutional ownership, profitability, analyst recommendations, valuation, earnings, dividends and risk.
Profitability
This table compares Summit Healthcare Acquisition and its rivals' net margins, return on equity and return on assets.
Get Summit Healthcare Acquisition alerts:| Net Margins | Return on Equity | Return on Assets | |
| Summit Healthcare Acquisition | N/A | 46.53% | 8.78% |
| Summit Healthcare Acquisition Competitors | 11.67% | -68.35% | 2.51% |
Valuation & Earnings
This table compares Summit Healthcare Acquisition and its rivals revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Summit Healthcare Acquisition | N/A | -$550,000.00 | 12.51 |
| Summit Healthcare Acquisition Competitors | $1.72 billion | $88.36 million | 25.15 |
Insider & Institutional Ownership
64.3% of shares of all "Holding & other investment offices" companies are held by institutional investors. 17.6% of shares of all "Holding & other investment offices" companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of current ratings and price targets for Summit Healthcare Acquisition and its rivals, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Summit Healthcare Acquisition | 0 | 0 | 0 | 0 | N/A |
| Summit Healthcare Acquisition Competitors | 113 | 591 | 885 | 18 | 2.50 |
As a group, "Holding & other investment offices" companies have a potential upside of 65.47%. Given Summit Healthcare Acquisition's rivals higher possible upside, analysts clearly believe Summit Healthcare Acquisition has less favorable growth aspects than its rivals.
Risk & Volatility
Summit Healthcare Acquisition has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500. Comparatively, Summit Healthcare Acquisition's rivals have a beta of 0.05, suggesting that their average share price is 95% less volatile than the S&P 500.
Summary
Summit Healthcare Acquisition rivals beat Summit Healthcare Acquisition on 8 of the 10 factors compared.
About Summit Healthcare Acquisition
(Get Rating)
Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.
Receive News & Ratings for Summit Healthcare Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Summit Healthcare Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
Summit Healthcare Acquisition (NASDAQ:SMIH – Get Rating) is one of 710 public companies in the "Holding & other investment offices" industry, but how does it contrast to its rivals? We will compare Summit Healthcare Acquisition to similar companies based on the strength of its institutional ownership, profitability, analyst recommendations, valuation, earnings, dividends and risk.
頂峰醫療收購(納斯達克：SMIH-GET評級)是“控股和其他投資辦公室”行業的710家上市公司之一，但它與競爭對手有何不同？我們將根據收購的機構所有權、盈利能力、分析師建議、估值、收益、股息和風險將Summit Healthcare收購與類似公司進行比較。
Profitability
盈利能力
This table compares Summit Healthcare Acquisition and its rivals' net margins, return on equity and return on assets.
此表比較了Summit Healthcare收購及其競爭對手的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Summit Healthcare Acquisition | N/A | 46.53% | 8.78% |
| Summit Healthcare Acquisition Competitors | 11.67% | -68.35% | 2.51% |
| 淨利潤率 | 股本回報率 | 資產回報率 | |
| Summit Healthcare收購 | 不適用 | 46.53% | 8.78% |
| Summit Healthcare收購競爭對手 | 11.67% | -68.35% | 2.51% |
Valuation & Earnings
估值與收益
This table compares Summit Healthcare Acquisition and its rivals revenue, earnings per share (EPS) and valuation.
此表比較了Summit Healthcare收購及其競爭對手的收入、每股收益(EPS)和估值。
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Summit Healthcare Acquisition | N/A | -$550,000.00 | 12.51 |
| Summit Healthcare Acquisition Competitors | $1.72 billion | $88.36 million | 25.15 |
| 總收入 | 淨收入 | 本益比 | |
| Summit Healthcare收購 | 不適用 | -$550,000.00 | 12.51 |
| Summit Healthcare收購競爭對手 | 17.2億美元 | 8836萬美元 | 25.15 |
Insider & Institutional Ownership
內部人與機構所有權
64.3% of shares of all "Holding & other investment offices" companies are held by institutional investors. 17.6% of shares of all "Holding & other investment offices" companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
所有“控股及其他投資辦事處”公司64.3%的股份由機構投資者持有。所有“控股及其他投資辦事處”公司17.6%的股份由內部人士持有。強大的機構持股表明，捐贈基金、大型基金管理公司和對沖基金相信，一家公司的長期表現將好於大盤。
Analyst Recommendations
分析師建議
This is a breakdown of current ratings and price targets for Summit Healthcare Acquisition and its rivals, as provided by MarketBeat.
這是由MarketBeat提供的Summit Healthcare Acquisition及其競爭對手的當前評級和目標價細分。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Summit Healthcare Acquisition | 0 | 0 | 0 | 0 | N/A |
| Summit Healthcare Acquisition Competitors | 113 | 591 | 885 | 18 | 2.50 |
| 銷售評級 | 保持評級 | 購買評級 | 強勁的買入評級 | 評級分數 | |
| Summit Healthcare收購 | 0 | 0 | 0 | 0 | 不適用 |
| Summit Healthcare收購競爭對手 | 113 | 591 | 885 | 18 | 2.50 |
As a group, "Holding & other investment offices" companies have a potential upside of 65.47%. Given Summit Healthcare Acquisition's rivals higher possible upside, analysts clearly believe Summit Healthcare Acquisition has less favorable growth aspects than its rivals.
作為一個整體，“控股和其他投資辦公室”公司有65.47%的潛在上行空間。考慮到Summit Healthcare收購的競爭對手更有可能的上行空間，分析師顯然認為Summit Healthcare收購的增長方面不如競爭對手有利。
Risk & Volatility
風險與波動性
Summit Healthcare Acquisition has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500. Comparatively, Summit Healthcare Acquisition's rivals have a beta of 0.05, suggesting that their average share price is 95% less volatile than the S&P 500.
Summit Healthcare收購的貝塔係數為0.01，表明其股價的波動性比標準普爾500指數低99%。相比之下，Summit Healthcare收購的競爭對手的貝塔係數為0.05，這表明它們的平均股價波動性比標準普爾500指數低95%。
Summary
摘要
Summit Healthcare Acquisition rivals beat Summit Healthcare Acquisition on 8 of the 10 factors compared.
Summit Healthcare收購的競爭對手在比較的10個因素中有8個擊敗了Summit Healthcare收購。
About Summit Healthcare Acquisition
關於Summit Healthcare收購
(Get Rating)
(獲取評級)
Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.
Summit Healthcare Acquisition Corp.沒有重大業務。擬與一個或者多個企業或者實體進行合併、換股、資產收購、股份購買、重組或者類似的業務合併。該公司成立於2020年，總部設在香港中環。
Receive News & Ratings for Summit Healthcare Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Summit Healthcare Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
收到Summit Healthcare收購日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Summit Healthcare收購和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧